PETV (PetVivo Holdings) Quality Rank

View and export this data going back to 2012. Start your Free Trial

What is PetVivo Holdings Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:

Interest coverage
Zscore
Debt to revenue
Equity to asset
Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:

Operating margin mean rank (10-year mean average profit margine)
Operating margin growth rank
Fscore
Predictability rank
Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
Num of year profit (number of years that is profitable within the last 10 years)
ROIC median (10-year median of ROIC)

PetVivo Holdings Quality Rank Related Terms

Thank you for viewing the detailed overview of PetVivo Holdings's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

PetVivo Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PetVivo Holdings Inc (OTCPK:PETV) » Definitions » Quality Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

5151 Edina Industrial Boulevard, Suite 575, Edina, MN, USA, 55439

Website

https://www.petvivo.com

PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.

Executives

John Lai	director, 10 percent owner, officer: CEO	12100 SINGLETREE LANE, SUITE 186, EDEN PRAIRIE MN 55344
James Rudolph Martin	director	POBOX 53988, IRVINE CA 92619
A.l. Sarroff Fund, Llc	10 percent owner	43 MEADOW WOODS ROAD, GREAT NECK NY 11020
John Spencer Breithaupt	director	3041 W. PASADENA DR., BOISE ID 83705
Robert J Costantino	director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joseph William Jasper	director	201 SOUTH 11TH STREET, UNIT 1030, MINNEAPOLIS MN 55403
Robert James Rudelius	director	6913 ARBOR LANE, MCCLEAN VA 22101
Leslie Anne Coolidge	director	345 OLD SUTTON ROAD, BARRINGTON HILLS IL 60010
Robert J. Folkes	officer: Chief Financial Officer	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Scott Mitchell Johnson	director	475 LAKESHORE UNIT #32, INCLINE VILLAGE NV 89451
James Joseph Martin	director	4400 BISCAYNE BLVD, SUITE # 670, MIAMI FL 33157
Gregory D Cash	director
John Michael Carruth	officer: Acting Chief Financial Officer	4923 RIVER WOOD DR., SAVAGE MN 55439
Sherry Grisewood	director	377 FAIRMOUNT ROAD, CALIFON NJ 07830
David Don Deming	director	16200 45TH STREET SOUTH, AFTON MN 55001